{"gene":"ADIPOQ","run_date":"2026-06-09T22:02:42","timeline":{"discoveries":[{"year":1996,"finding":"ADIPOQ (GBP28/apM1) was isolated from human plasma as a gelatin-binding protein. Structural analysis revealed it is encoded by the adipose-specific apM1 cDNA and contains a secretory signal sequence, collagen-like repeats, and a globular C-terminal domain, enabling homo-trimer formation and higher-order oligomeric complexes via its collagen-like domain.","method":"Affinity purification on gelatin-Cellulofine, N-terminal amino acid sequencing, protease peptide mapping, SDS-PAGE under reducing and non-reducing conditions, gel chromatography, cDNA sequence matching","journal":"Journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct biochemical purification and structural characterization with multiple orthogonal methods in the founding paper","pmids":["8947845"],"is_preprint":false},{"year":2001,"finding":"A single injection of recombinant Acrp30 in mice transiently lowered basal glucose levels and abolished hyperglycemia in ob/ob, NOD, and streptozotocin-treated mice independent of changes in insulin levels. In isolated hepatocytes, Acrp30 enhanced the ability of sub-physiological insulin to suppress glucose production, identifying the liver as a primary target organ.","method":"Intraperitoneal injection of purified recombinant protein in multiple mouse models; isolated hepatocyte glucose production assay","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo rescue experiments in multiple disease models plus ex vivo hepatocyte assay; replicated across conditions","pmids":["11479628"],"is_preprint":false},{"year":2001,"finding":"Acrp30 infusion during a pancreatic euglycemic clamp in conscious mice caused a ~65% reduction in endogenous glucose production and reduced hepatic gluconeogenic enzyme mRNAs (PEPCK and G6Pase) by >50%, without affecting peripheral glucose uptake, glycolysis, or glycogen synthesis, establishing hepatic gluconeogenesis suppression as the primary mechanism of Acrp30-mediated glucose lowering.","method":"Pancreatic euglycemic clamp with intravenous Acrp30 infusion; isotopic glucose flux measurements; hepatic enzyme mRNA quantification","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1 / Strong — quantitative in vivo clamp methodology with isotopic tracers and molecular readouts, single rigorous study with multiple orthogonal methods","pmids":["11748271"],"is_preprint":false},{"year":2002,"finding":"Adiponectin/ACRP30 knockout mice showed delayed clearance of plasma free fatty acids, reduced FATP-1 mRNA in muscle, elevated adipose TNF-alpha mRNA and plasma TNF-alpha, and severe diet-induced insulin resistance with reduced IRS-1-associated PI3-kinase activity in muscle. Viral re-expression of adiponectin reversed these defects, placing adiponectin upstream of FATP-1 expression and IRS-1-mediated insulin signaling in muscle.","method":"Gene knockout mouse model, viral-mediated gene rescue, muscle PI3-kinase activity assay, cultured myocyte TNF-alpha/adiponectin treatment","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic KO with specific molecular phenotype, rescue experiment, and in vitro validation; multiple orthogonal methods","pmids":["12068289"],"is_preprint":false},{"year":2002,"finding":"Acrp30 circulates as trimeric and high-molecular-weight (HMW) oligomeric complexes whose distribution shows sexual dimorphism (females have more HMW). Disulfide bonds via Cys-39 are required for HMW complex formation. Mutation of Cys-39 (C39S) produces trimers that are more bioactive than HMW forms in reducing serum glucose and suppressing hepatic glucose output in primary hepatocytes, demonstrating that oligomerization state regulates bioactivity.","method":"SDS-PAGE, size-exclusion chromatography, site-directed mutagenesis (Cys-39), DTT reduction, in vivo glucose assay, primary hepatocyte glucose output assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis combined with in vitro and in vivo functional assays in a single rigorous study","pmids":["12496257"],"is_preprint":false},{"year":2002,"finding":"Hexameric and higher molecular weight (HMW) isoforms of Acrp30 activate NF-κB in C2C12 myocytes via phosphorylation and degradation of IκB-alpha, whereas trimeric Acrp30 and globular domain (gAcrp30) do not, establishing oligomerization-state-dependent NF-κB signaling.","method":"NF-κB reporter assay, Western blot for IκB-α phosphorylation/degradation, size-fractionated Acrp30 preparations from E. coli and HEK293T cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical fractionation combined with functional reporter and mechanistic Western blot in a single study","pmids":["12087086"],"is_preprint":false},{"year":2003,"finding":"Trimeric Acrp30 (but not hexameric or HMW forms) activates AMP-activated protein kinase alpha (phosphorylation at Thr172) in isolated rat muscle. Conversely, HMW and hexameric Acrp30 activate NF-κB but trimers do not. Cys-22 disulfide bonds are required for hexamer/HMW formation but not trimer stability, establishing that different oligomeric forms activate distinct signaling pathways.","method":"Freeze-etch electron microscopy, site-directed mutagenesis (Cys22 to Ala), DTT reduction, AMPK phosphorylation assay in isolated muscle, NF-κB reporter assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — structural EM, mutagenesis, and orthogonal functional assays in a single rigorous study","pmids":["14522956"],"is_preprint":false},{"year":2004,"finding":"T-cadherin was identified as a binding receptor for hexameric and HMW species of adiponectin, but not for trimeric or globular species. Binding requires eukaryotic post-translational modifications on adiponectin and the N-terminal cysteine required for hexamer/HMW formation; a C-terminal cysteine mutant that cannot form hexamers/HMW failed to bind T-cadherin in co-immunoprecipitation.","method":"Retroviral cDNA expression library screen, magnetic bead panning for adiponectin binding, co-immunoprecipitation, T-cadherin overexpression in Ba/F3 cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — expression cloning-based receptor identification confirmed by Co-IP and isoform-specific binding assays with mutagenesis","pmids":["15210937"],"is_preprint":false},{"year":2006,"finding":"APPL1 (adaptor protein with PTB, PH and leucine zipper domains) was identified as a direct binding partner of AdipoR1 intracellular domain by yeast two-hybrid. APPL1 interaction with adiponectin receptors in mammalian cells is stimulated by adiponectin. APPL1 overexpression increases, and APPL1 knockdown reduces, adiponectin-stimulated lipid oxidation, glucose uptake, and GLUT4 membrane translocation. Adiponectin also stimulates APPL1–Rab5 interaction, promoting GLUT4 translocation. APPL1 mediates cross-talk between adiponectin and insulin signaling pathways.","method":"Yeast two-hybrid screening, co-immunoprecipitation in mammalian cells, APPL1 overexpression/siRNA knockdown, lipid oxidation assay, glucose uptake assay, GLUT4 translocation assay","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid discovery confirmed by reciprocal Co-IP, multiple orthogonal functional readouts, gain- and loss-of-function","pmids":["16622416"],"is_preprint":false},{"year":1999,"finding":"The GBP28/ADIPOQ gene was mapped to human chromosome 3q27 by FISH and found to span 16 kb with 3 exons and 2 introns. The gene lacks a TATA box and its exon-intron organization resembles the leptin gene, providing structural basis for understanding its transcriptional regulation.","method":"Genomic cloning (lambda and BAC clones), FISH chromosomal mapping, sequence analysis of exon-intron boundaries","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct genomic structural characterization by cloning and FISH; single lab, primarily structural without functional validation","pmids":["10095105"],"is_preprint":false},{"year":2001,"finding":"GBP28/adiponectin expression is normally absent in mouse liver, but after CCl4-induced hepatic injury, circulating GBP28 binds to hepatocyte extracellular matrix early (3–6 h), and GBP28 mRNA is subsequently markedly induced in damaged hepatocytes. IL-6 treatment of human HepG2 hepatoma cells also induced GBP28 expression, identifying liver as a secondary production site regulated by injury and inflammatory signals.","method":"Immunohistochemistry, quantitative RT-PCR, in situ hybridization in CCl4-treated mouse liver; IL-6 treatment of HepG2 cells","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple detection methods (IHC, qRT-PCR, ISH) in vivo plus in vitro IL-6 stimulation; single lab","pmids":["11444852"],"is_preprint":false},{"year":2001,"finding":"Mouse Acrp30 gene was mapped to the telomere of chromosome 16 (syntenic to human 3q27), and alternative polyadenylation produces two distinct mRNA species. Acrp30 expression is induced only at late stages of mouse embryonic development. The promoter was shown to drive strong adipocyte-specific expression in tissue culture cells.","method":"Chromosomal mapping, RT-PCR for alternative polyadenylation, developmental expression analysis, promoter-reporter assays in tissue culture","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct experimental mapping and promoter functional assay; single lab with multiple orthogonal methods","pmids":["11162643"],"is_preprint":false},{"year":2010,"finding":"AdipoR1 forms endogenous homodimers in multiple cell lines and human muscle tissue. A GxxxG motif in the fifth transmembrane domain is required for dimerization; mutation of both glycines (to Phe or Glu) disrupts dimerization. Adiponectin decreases AdipoR1 dimerization in a concentration-dependent manner, with this effect primarily mediated by the collagen-like domain of full-length adiponectin.","method":"Bimolecular fluorescence complementation (BiFC), flow cytometry, site-directed mutagenesis of GxxxG motif, Western blot of endogenous AdipoR1 in human muscle","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of specific dimerization motif combined with BiFC and endogenous protein detection; single lab with multiple orthogonal methods","pmids":["20332107"],"is_preprint":false},{"year":2000,"finding":"TNF-alpha reduces apM1 expression and secretion in differentiating primary human preadipocytes, while dibutyryl-cAMP also reduces expression. Ionomycin increases secretion of apM1. These findings establish transcriptional/secretory regulatory mechanisms for ADIPOQ in human adipocytes.","method":"Primary human preadipocyte differentiation culture, polyclonal antibody for apM1 detection, pharmacological treatments (ionomycin, db-cAMP, TNF-alpha), glycerol-3-phosphate dehydrogenase activity as differentiation marker","journal":"Hormone and metabolic research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct measurement of protein expression and secretion with multiple pharmacological treatments; single lab, no rescue or mechanistic depth","pmids":["11246823"],"is_preprint":false},{"year":2015,"finding":"Uncarboxylated osteocalcin (GluOC) induces adiponectin expression in adipocytes via GPRC6A receptor activation → cAMP accumulation → PKA activation → Src → Rap1 → ERK → CREB phosphorylation → PPARγ upregulation → adiponectin expression. ERK inhibition (U0126) blocked CREB phosphorylation. In vivo, oral GluOC in mice increased PPARγ and adiponectin expression in gonadal white adipocytes.","method":"3T3-L1 adipocyte differentiation assay, pharmacological inhibitors (U0126, PKA inhibitors), Western blot for signaling intermediates, in vivo mouse oral GluOC administration","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway dissection with pharmacological inhibitors and in vivo confirmation; single lab","pmids":["25562427"],"is_preprint":false},{"year":2012,"finding":"Adiponectin/AdipoR1 signaling in muscle regulates mitochondrial biogenesis via AMPK- and SIRT1-mediated PGC-1α activation and Ca2+-dependent upregulation of PGC-1α expression. Muscle-specific AdipoR1 knockout mice had impaired mitochondrial biogenesis and insulin resistance, revealing this as the mechanistic basis for adiponectin's insulin-sensitizing effect in muscle.","method":"Muscle-specific AdipoR1 knockout mouse, mitochondrial biogenesis assays, AMPK/SIRT1/PGC-1α pathway analysis","journal":"Cold Spring Harbor symposia on quantitative biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — tissue-specific genetic knockout with specific molecular phenotype; single lab, conference proceedings (less rigorous venue)","pmids":["22492282"],"is_preprint":false},{"year":2014,"finding":"Macrophage polarization state controls AdipoR1/R2 expression and adiponectin signaling outcome: classical M1 activation suppresses AdipoR expression (40–60% reduction) and causes adiponectin to induce pro-inflammatory cytokines (TNF-α, IL-6, IL-12 >10-fold), whereas M2 activation preserves AdipoR expression and adiponectin induces anti-inflammatory IL-10. Adiponectin upregulates AdipoR mRNA and protein in macrophages via LXRα.","method":"Mouse bone marrow and peritoneal macrophage polarization, cytokine ELISA/multiplex, AdipoR mRNA/protein quantification, LXRα pathway analysis","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple cell types, defined polarization conditions, mechanistic pathway (LXRα); single lab","pmids":["25392268"],"is_preprint":false},{"year":2012,"finding":"Acrp30 inhibits leptin-induced invasion of SPEC-2 endometrial cancer cells by activating AMPK and thereby reducing STAT3 phosphorylation and nuclear translocation, with downstream reduction of MMP-2 and MMP-9. JAK/STAT3 inhibitor and AMPK inhibitor experiments confirmed the pathway: Acrp30 acts via AMPK to suppress the JAK/STAT3 axis activated by leptin.","method":"Matrigel transwell invasion assay, Western blot for STAT3 phosphorylation, cell immunofluorescence for STAT3 nuclear translocation, pharmacological inhibitors (AG490, Compound C, IL-6), qRT-PCR for MMP-2/MMP-9","journal":"Oncology reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway placed by pharmacological epistasis with multiple inhibitors and multiple molecular readouts; single lab","pmids":["22327423"],"is_preprint":false},{"year":2021,"finding":"Adiponectin null mice display exacerbated age-related glucose and lipid metabolism disorders and shortened lifespan on both chow and high-fat diet. Transgenic mice with elevated circulating adiponectin have improved systemic insulin sensitivity, reduced age-related tissue inflammation and fibrosis, and prolonged healthspan and median lifespan, establishing adiponectin as a direct regulator of aging and longevity.","method":"Adiponectin knockout mouse aging study, adiponectin transgenic overexpression mouse, glucose/lipid metabolism assays, histological assessment of tissue inflammation and fibrosis, lifespan analysis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — bidirectional genetic manipulation (KO and transgenic overexpression) with specific metabolic and longevity phenotypes; rigorous experimental design","pmids":["33904399"],"is_preprint":false}],"current_model":"ADIPOQ (adiponectin/Acrp30/GBP28) is an adipocyte-secreted collagen-domain-containing protein that circulates as trimeric, hexameric, and high-molecular-weight oligomers; trimers preferentially activate AMP-activated protein kinase (AMPK) in muscle while hexameric/HMW forms activate NF-κB, and HMW forms bind T-cadherin on vascular cells. Its primary metabolic actions are suppression of hepatic gluconeogenesis (reducing PEPCK and G6Pase expression) and enhancement of muscle fatty acid oxidation and glucose uptake via IRS-1/PI3-kinase and AMPK/SIRT1/PGC-1α pathways, with APPL1 serving as the intracellular adaptor linking AdipoR1/R2 to downstream signaling including GLUT4 translocation and cross-talk with insulin signaling."},"narrative":{"mechanistic_narrative":"ADIPOQ encodes adiponectin (GBP28/apM1/Acrp30), an adipocyte-secreted, collagen-domain protein that acts as a systemic regulator of glucose and lipid metabolism, insulin sensitivity, and organismal healthspan [PMID:8947845, PMID:33904399]. Originally purified from plasma as a gelatin-binding protein with a signal sequence, collagen-like repeats, and a globular C-terminal domain, it assembles into trimers, hexamers, and high-molecular-weight (HMW) oligomers, with interchain disulfide bonds through Cys-39/Cys-22 required for higher-order assembly [PMID:8947845, PMID:12496257, PMID:14522956]. Oligomerization state dictates signaling output: trimers preferentially activate AMPK (Thr172 phosphorylation) in muscle, while hexameric and HMW forms drive NF-κB signaling via IκB-α degradation, and only hexamer/HMW species bind the receptor T-cadherin in a manner dependent on eukaryotic post-translational modification [PMID:12496257, PMID:12087086, PMID:14522956, PMID:15210937]. Its principal metabolic action is suppression of hepatic glucose output — in vivo it reduces endogenous glucose production and downregulates the gluconeogenic enzymes PEPCK and G6Pase, sensitizing the liver to insulin [PMID:11479628, PMID:11748271]. In muscle, adiponectin signaling supports IRS-1-associated PI3-kinase activity, FATP-1 expression, free fatty acid clearance, and AMPK/SIRT1/PGC-1α-driven mitochondrial biogenesis, as established by adiponectin and muscle-specific AdipoR1 knockouts [PMID:12068289, PMID:22492282]. Intracellular signal transmission depends on the adaptor APPL1, which binds the AdipoR1 cytoplasmic domain, is recruited upon adiponectin stimulation, and links receptor engagement to lipid oxidation, glucose uptake, GLUT4 translocation (via Rab5), and cross-talk with insulin signaling [PMID:16622416]. Adiponectin expression is regulated transcriptionally — suppressed by TNF-α and induced through a GPRC6A→cAMP/PKA→ERK/CREB→PPARγ axis by uncarboxylated osteocalcin — and its actions extend to context-dependent modulation of macrophage inflammation and lifespan extension [PMID:11246823, PMID:25562427, PMID:25392268, PMID:33904399].","teleology":[{"year":1996,"claim":"Established the molecular identity and architecture of adiponectin, defining the structural basis for its oligomerization.","evidence":"Affinity purification from human plasma, N-terminal sequencing, peptide mapping, and reducing/non-reducing SDS-PAGE","pmids":["8947845"],"confidence":"High","gaps":["Did not define receptors or signaling","Functional role of oligomers unaddressed at this stage"]},{"year":1999,"claim":"Mapped the gene to 3q27 and characterized its exon-intron and promoter structure, providing the genomic basis for transcriptional regulation.","evidence":"Genomic cloning and FISH chromosomal mapping with exon-intron boundary sequencing","pmids":["10095105","11162643"],"confidence":"Medium","gaps":["No functional transcription factor identification","Promoter activity only shown in tissue culture"]},{"year":2001,"claim":"Identified the liver as a primary target and pinpointed suppression of hepatic gluconeogenesis as the dominant glucose-lowering mechanism, distinguishing it from peripheral glucose uptake.","evidence":"Recombinant protein injection in multiple diabetic mouse models, hepatocyte glucose-production assays, and pancreatic euglycemic clamp with isotopic tracers and PEPCK/G6Pase mRNA quantification","pmids":["11479628","11748271"],"confidence":"High","gaps":["Receptor mediating hepatic action not identified","Did not connect to specific oligomeric form"]},{"year":2002,"claim":"Genetic loss-of-function placed adiponectin upstream of muscle FATP-1 expression and IRS-1/PI3-kinase insulin signaling, mechanistically linking it to insulin resistance.","evidence":"Adiponectin knockout mouse with viral rescue, muscle PI3-kinase activity assays, and myocyte treatment","pmids":["12068289"],"confidence":"High","gaps":["Did not resolve receptor or intracellular adaptor","Relationship between TNF-α elevation and insulin resistance correlative"]},{"year":2002,"claim":"Demonstrated that oligomerization state — controlled by Cys-39 disulfide bonds — determines bioactivity and signaling pathway selection.","evidence":"Size-exclusion chromatography, Cys-39 mutagenesis, in vivo glucose assays, hepatocyte glucose output, and NF-κB reporter/IκB-α Western blots with size-fractionated preparations","pmids":["12496257","12087086"],"confidence":"High","gaps":["Receptors for distinct oligomers not yet identified","Physiological determinants of oligomer distribution beyond sex unclear"]},{"year":2003,"claim":"Resolved that trimers selectively activate AMPK while hexamer/HMW forms selectively activate NF-κB, formalizing oligomer-specific pathway routing.","evidence":"Freeze-etch EM, Cys-22 mutagenesis, AMPK Thr172 phosphorylation in isolated muscle, and NF-κB reporter assays","pmids":["14522956"],"confidence":"High","gaps":["Receptor coupling each oligomer to its pathway not defined","In vivo relevance of NF-κB branch unaddressed"]},{"year":2004,"claim":"Identified T-cadherin as an oligomer-selective receptor binding hexamer/HMW species, explaining how oligomeric state confers receptor specificity.","evidence":"Retroviral expression cloning, magnetic-bead panning, co-immunoprecipitation, and isoform-specific binding with cysteine mutants","pmids":["15210937"],"confidence":"High","gaps":["Downstream signaling from T-cadherin not established","T-cadherin lacks intracellular domain, leaving transduction mechanism open"]},{"year":2006,"claim":"Identified APPL1 as the intracellular adaptor coupling AdipoR1 to metabolic effectors and insulin cross-talk, providing the missing intracellular link.","evidence":"Yeast two-hybrid, reciprocal Co-IP, gain/loss-of-function, and lipid oxidation, glucose uptake, and GLUT4 translocation assays","pmids":["16622416"],"confidence":"High","gaps":["Structural basis of APPL1–AdipoR1 interaction not defined","Relationship to AMPK activation branch incompletely resolved"]},{"year":2010,"claim":"Showed AdipoR1 forms GxxxG-dependent homodimers that adiponectin disrupts, indicating ligand-regulated receptor oligomerization as a signaling event.","evidence":"BiFC, flow cytometry, GxxxG-motif mutagenesis, and endogenous AdipoR1 detection in human muscle","pmids":["20332107"],"confidence":"High","gaps":["Functional consequence of dimer disruption for downstream signaling not quantified","Whether AdipoR2 behaves identically untested"]},{"year":2012,"claim":"Mechanistically tied muscle AdipoR1 signaling to AMPK/SIRT1/PGC-1α-driven mitochondrial biogenesis as the basis of insulin sensitization.","evidence":"Muscle-specific AdipoR1 knockout mice with mitochondrial biogenesis and pathway analyses","pmids":["22492282"],"confidence":"Medium","gaps":["Conference-proceedings venue","Ca2+ and AMPK contributions not fully separated"]},{"year":2012,"claim":"Extended adiponectin's AMPK action beyond metabolism, showing it suppresses leptin-driven JAK/STAT3 signaling and MMP expression in cancer cells.","evidence":"Invasion assays, STAT3 phosphorylation/nuclear-translocation analysis, and pharmacological epistasis (AG490, Compound C)","pmids":["22327423"],"confidence":"Medium","gaps":["Single cell line","Receptor mediating the anti-invasive effect not identified"]},{"year":2014,"claim":"Defined the upstream transcriptional regulation of adiponectin and the macrophage-state-dependence of its inflammatory output.","evidence":"Macrophage polarization with cytokine profiling and LXRα analysis; preadipocyte differentiation with pharmacological treatments (TNF-α, cAMP, ionomycin)","pmids":["25392268","11246823"],"confidence":"Medium","gaps":["Direct transcription factors at the ADIPOQ promoter not fully mapped","In vivo relevance of macrophage polarization switch untested"]},{"year":2015,"claim":"Identified an osteocalcin–GPRC6A signaling cascade that induces adiponectin via PPARγ, linking bone-derived signals to adipokine expression.","evidence":"3T3-L1 differentiation, pharmacological inhibitor dissection (U0126, PKA inhibitors), and in vivo oral GluOC administration","pmids":["25562427"],"confidence":"Medium","gaps":["Single lab","Quantitative contribution to circulating adiponectin in vivo unclear"]},{"year":2021,"claim":"Bidirectional genetic manipulation established adiponectin as a direct regulator of healthspan and lifespan, not merely acute metabolism.","evidence":"Adiponectin knockout and transgenic overexpression mouse lifespan studies with metabolic and histological assessment","pmids":["33904399"],"confidence":"High","gaps":["Molecular mediators of longevity effect not pinpointed","Whether oligomer- or receptor-specific signaling underlies the phenotype unresolved"]},{"year":null,"claim":"How distinct oligomeric forms are coupled to specific receptors (AdipoR1/R2, T-cadherin) and intracellular adaptors to produce divergent metabolic, inflammatory, and longevity outcomes in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified structural model linking oligomer to receptor to pathway","T-cadherin transduction mechanism undefined","Mediators of lifespan extension unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[1,7,8]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,3,6]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,4,6]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,1,4]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[10]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,8]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,3,15]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[5,16]}],"complexes":[],"partners":["CDH13","APPL1","ADIPOR1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q15848","full_name":"Adiponectin","aliases":["30 kDa adipocyte complement-related protein","Adipocyte complement-related 30 kDa protein","ACRP30","Adipocyte, C1q and collagen domain-containing protein","Adipose most abundant gene transcript 1 protein","apM-1","Gelatin-binding protein"],"length_aa":244,"mass_kda":26.4,"function":"Important adipokine involved in the control of fat metabolism and insulin sensitivity, with direct anti-diabetic, anti-atherogenic and anti-inflammatory activities. Stimulates AMPK phosphorylation and activation in the liver and the skeletal muscle, enhancing glucose utilization and fatty-acid combustion. Antagonizes TNF by negatively regulating its expression in various tissues such as liver and macrophages, and also by counteracting its effects. Inhibits endothelial NF-kappa-B signaling through a cAMP-dependent pathway. May play a role in cell growth, angiogenesis and tissue remodeling by binding and sequestering various growth factors with distinct binding affinities, depending on the type of complex, LMW, MMW or HMW","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/Q15848/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ADIPOQ","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ADIPOQ","total_profiled":1310},"omim":[{"mim_id":"620225","title":"SUPPRESSOR OF GLUCOSE, AUTOPHAGY-ASSOCIATED PROTEIN 1; SOGA1","url":"https://www.omim.org/entry/620225"},{"mim_id":"620018","title":"PROTEIN DISULFIDE ISOMERASE, FAMILY A, MEMBER 4; PDIA4","url":"https://www.omim.org/entry/620018"},{"mim_id":"618647","title":"C1q- AND TNF-RELATED PROTEIN 2; C1QTNF2","url":"https://www.omim.org/entry/618647"},{"mim_id":"615603","title":"CALCINEURIN-LIKE PHOSPHOESTERASE DOMAIN-CONTAINING PROTEIN 1; CPPED1","url":"https://www.omim.org/entry/615603"},{"mim_id":"615229","title":"COMPLEMENT COMPONENT 1, q SUBCOMPONENT-LIKE 4; C1QL4","url":"https://www.omim.org/entry/615229"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":843.2},{"tissue":"breast","ntpm":252.6}],"url":"https://www.proteinatlas.org/search/ADIPOQ"},"hgnc":{"alias_symbol":["ACRP30","apM1","GBP28","adiponectin"],"prev_symbol":["ACDC"]},"alphafold":{"accession":"Q15848","domains":[{"cath_id":"2.60.120.40","chopping":"113-240","consensus_level":"high","plddt":95.8291,"start":113,"end":240}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15848","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15848-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15848-F1-predicted_aligned_error_v6.png","plddt_mean":79.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ADIPOQ","jax_strain_url":"https://www.jax.org/strain/search?query=ADIPOQ"},"sequence":{"accession":"Q15848","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15848.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15848/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15848"}},"corpus_meta":[{"pmid":"16823476","id":"PMC_16823476","title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome.","date":"2006","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/16823476","citation_count":2177,"is_preprint":false},{"pmid":"11479628","id":"PMC_11479628","title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.","date":"2001","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11479628","citation_count":2036,"is_preprint":false},{"pmid":"15897298","id":"PMC_15897298","title":"Adiponectin and adiponectin receptors.","date":"2005","source":"Endocrine reviews","url":"https://pubmed.ncbi.nlm.nih.gov/15897298","citation_count":1978,"is_preprint":false},{"pmid":"12068289","id":"PMC_12068289","title":"Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.","date":"2002","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12068289","citation_count":1669,"is_preprint":false},{"pmid":"11854024","id":"PMC_11854024","title":"ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism.","date":"2002","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/11854024","citation_count":949,"is_preprint":false},{"pmid":"12496257","id":"PMC_12496257","title":"Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12496257","citation_count":875,"is_preprint":false},{"pmid":"11748271","id":"PMC_11748271","title":"Endogenous glucose production is inhibited by the adipose-derived protein Acrp30.","date":"2001","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/11748271","citation_count":719,"is_preprint":false},{"pmid":"8947845","id":"PMC_8947845","title":"Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma.","date":"1996","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8947845","citation_count":698,"is_preprint":false},{"pmid":"15210937","id":"PMC_15210937","title":"T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15210937","citation_count":671,"is_preprint":false},{"pmid":"14624132","id":"PMC_14624132","title":"Obesity, adiponectin and vascular inflammatory disease.","date":"2003","source":"Current opinion in lipidology","url":"https://pubmed.ncbi.nlm.nih.gov/14624132","citation_count":576,"is_preprint":false},{"pmid":"16622416","id":"PMC_16622416","title":"APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function.","date":"2006","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16622416","citation_count":551,"is_preprint":false},{"pmid":"29978896","id":"PMC_29978896","title":"Adiponectin Regulation and Function.","date":"2018","source":"Comprehensive Physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29978896","citation_count":485,"is_preprint":false},{"pmid":"23266767","id":"PMC_23266767","title":"Role of leptin and adiponectin in insulin resistance.","date":"2012","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23266767","citation_count":469,"is_preprint":false},{"pmid":"14522956","id":"PMC_14522956","title":"Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14522956","citation_count":392,"is_preprint":false},{"pmid":"15231994","id":"PMC_15231994","title":"A family of Acrp30/adiponectin structural and functional paralogs.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15231994","citation_count":359,"is_preprint":false},{"pmid":"12087086","id":"PMC_12087086","title":"Oligomerization state-dependent activation of NF-kappa B signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30).","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12087086","citation_count":307,"is_preprint":false},{"pmid":"17140553","id":"PMC_17140553","title":"Adiponectin actions in the cardiovascular system.","date":"2006","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/17140553","citation_count":257,"is_preprint":false},{"pmid":"20963555","id":"PMC_20963555","title":"Adiponectin action from head to toe.","date":"2009","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/20963555","citation_count":248,"is_preprint":false},{"pmid":"33088464","id":"PMC_33088464","title":"Adiponectin: Role in Physiology and Pathophysiology.","date":"2020","source":"International journal of preventive medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33088464","citation_count":245,"is_preprint":false},{"pmid":"21718299","id":"PMC_21718299","title":"Adiponectin receptor signalling in the brain.","date":"2012","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21718299","citation_count":240,"is_preprint":false},{"pmid":"18854421","id":"PMC_18854421","title":"APPL1: role in adiponectin signaling and beyond.","date":"2008","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18854421","citation_count":235,"is_preprint":false},{"pmid":"19029992","id":"PMC_19029992","title":"Protective vascular and myocardial effects of adiponectin.","date":"2008","source":"Nature clinical practice. Cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19029992","citation_count":232,"is_preprint":false},{"pmid":"18054335","id":"PMC_18054335","title":"The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS.","date":"2007","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/18054335","citation_count":210,"is_preprint":false},{"pmid":"12007537","id":"PMC_12007537","title":"ACRP30, a new hormone controlling fat and glucose metabolism.","date":"2002","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12007537","citation_count":203,"is_preprint":false},{"pmid":"15149866","id":"PMC_15149866","title":"Adiponectin and atherosclerotic disease.","date":"2004","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15149866","citation_count":180,"is_preprint":false},{"pmid":"19359049","id":"PMC_19359049","title":"Adiponectin in health and disease: evaluation of adiponectin-targeted drug development strategies.","date":"2009","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/19359049","citation_count":176,"is_preprint":false},{"pmid":"16443770","id":"PMC_16443770","title":"Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16443770","citation_count":175,"is_preprint":false},{"pmid":"19261992","id":"PMC_19261992","title":"Adiponectin and cardiovascular disease.","date":"2009","source":"Circulation journal : official journal of the Japanese Circulation Society","url":"https://pubmed.ncbi.nlm.nih.gov/19261992","citation_count":168,"is_preprint":false},{"pmid":"18069030","id":"PMC_18069030","title":"Adiponectin: an update.","date":"2008","source":"Diabetes & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18069030","citation_count":160,"is_preprint":false},{"pmid":"11469400","id":"PMC_11469400","title":"Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes.","date":"2000","source":"International journal of experimental diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/11469400","citation_count":155,"is_preprint":false},{"pmid":"11246823","id":"PMC_11246823","title":"Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes.","date":"2000","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/11246823","citation_count":150,"is_preprint":false},{"pmid":"15705753","id":"PMC_15705753","title":"Expression of adiponectin and its receptors in swine.","date":"2005","source":"Journal of animal science","url":"https://pubmed.ncbi.nlm.nih.gov/15705753","citation_count":141,"is_preprint":false},{"pmid":"16443793","id":"PMC_16443793","title":"ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16443793","citation_count":130,"is_preprint":false},{"pmid":"18698133","id":"PMC_18698133","title":"Expression of adiponectin and adiponectin receptors in human pituitary gland and brain.","date":"2008","source":"Neuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18698133","citation_count":127,"is_preprint":false},{"pmid":"24417951","id":"PMC_24417951","title":"Adiponectin as a routine clinical biomarker.","date":"2013","source":"Best practice & research. Clinical endocrinology & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24417951","citation_count":120,"is_preprint":false},{"pmid":"24170312","id":"PMC_24170312","title":"Adiponectin and energy homeostasis.","date":"2014","source":"Reviews in endocrine & metabolic disorders","url":"https://pubmed.ncbi.nlm.nih.gov/24170312","citation_count":118,"is_preprint":false},{"pmid":"14749263","id":"PMC_14749263","title":"Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish caucasians.","date":"2004","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/14749263","citation_count":118,"is_preprint":false},{"pmid":"24297186","id":"PMC_24297186","title":"Adiponectin signaling in the liver.","date":"2014","source":"Reviews in endocrine & metabolic disorders","url":"https://pubmed.ncbi.nlm.nih.gov/24297186","citation_count":114,"is_preprint":false},{"pmid":"27629236","id":"PMC_27629236","title":"Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease.","date":"2016","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27629236","citation_count":112,"is_preprint":false},{"pmid":"32188008","id":"PMC_32188008","title":"Adiponectin and Cognitive Decline.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32188008","citation_count":110,"is_preprint":false},{"pmid":"15830179","id":"PMC_15830179","title":"Hypoadiponectinaemia and high risk of type 2 diabetes are associated with adiponectin-encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role of ACDC in diabesity.","date":"2005","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/15830179","citation_count":108,"is_preprint":false},{"pmid":"15544426","id":"PMC_15544426","title":"Adiponectin, an adipocyte-derived protein.","date":"2005","source":"Physiological research","url":"https://pubmed.ncbi.nlm.nih.gov/15544426","citation_count":101,"is_preprint":false},{"pmid":"11444852","id":"PMC_11444852","title":"Change in expression of GBP28/adiponectin in carbon tetrachloride-administrated mouse liver.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11444852","citation_count":100,"is_preprint":false},{"pmid":"28585210","id":"PMC_28585210","title":"Adiponectin-Resistance in Obesity.","date":"2017","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/28585210","citation_count":99,"is_preprint":false},{"pmid":"10095105","id":"PMC_10095105","title":"Organization of the gene for gelatin-binding protein (GBP28).","date":"1999","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/10095105","citation_count":98,"is_preprint":false},{"pmid":"15616038","id":"PMC_15616038","title":"Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene.","date":"2005","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/15616038","citation_count":97,"is_preprint":false},{"pmid":"15589686","id":"PMC_15589686","title":"Adiponectin, obesity, and cardiovascular disease.","date":"2004","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/15589686","citation_count":95,"is_preprint":false},{"pmid":"14683455","id":"PMC_14683455","title":"Dual roles of adiponectin/Acrp30 in vivo as an anti-diabetic and anti-atherogenic adipokine.","date":"2003","source":"Current drug targets. Immune, endocrine and metabolic disorders","url":"https://pubmed.ncbi.nlm.nih.gov/14683455","citation_count":94,"is_preprint":false},{"pmid":"30974901","id":"PMC_30974901","title":"Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30974901","citation_count":87,"is_preprint":false},{"pmid":"20536390","id":"PMC_20536390","title":"Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors.","date":"2010","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20536390","citation_count":85,"is_preprint":false},{"pmid":"33904399","id":"PMC_33904399","title":"Adiponectin preserves metabolic fitness during aging.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33904399","citation_count":83,"is_preprint":false},{"pmid":"25562427","id":"PMC_25562427","title":"Signaling pathway for adiponectin expression in adipocytes by osteocalcin.","date":"2015","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25562427","citation_count":82,"is_preprint":false},{"pmid":"25392268","id":"PMC_25392268","title":"Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/25392268","citation_count":82,"is_preprint":false},{"pmid":"28721260","id":"PMC_28721260","title":"Adiponectin/adiponectin receptor in disease and aging.","date":"2015","source":"NPJ aging and mechanisms of disease","url":"https://pubmed.ncbi.nlm.nih.gov/28721260","citation_count":75,"is_preprint":false},{"pmid":"20875820","id":"PMC_20875820","title":"Adiponectin receptor binding proteins--recent advances in elucidating adiponectin signalling pathways.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20875820","citation_count":74,"is_preprint":false},{"pmid":"19207481","id":"PMC_19207481","title":"Adiponectin, an unlocking adipocytokine.","date":"2009","source":"Cardiovascular therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/19207481","citation_count":72,"is_preprint":false},{"pmid":"21106494","id":"PMC_21106494","title":"Adiponectin and adiponectin receptors in the mouse preimplantation embryo and uterus.","date":"2010","source":"Human reproduction (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21106494","citation_count":72,"is_preprint":false},{"pmid":"17903323","id":"PMC_17903323","title":"Adiponectin, the controversial hormone.","date":"2007","source":"Public health nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/17903323","citation_count":69,"is_preprint":false},{"pmid":"15616040","id":"PMC_15616040","title":"Common Polymorphisms in the Adiponectin Gene ACDC Are Not Associated With Diabetes in Pima Indians.","date":"2005","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/15616040","citation_count":69,"is_preprint":false},{"pmid":"16033679","id":"PMC_16033679","title":"Adiponectin and human pregnancy.","date":"2005","source":"Current diabetes reports","url":"https://pubmed.ncbi.nlm.nih.gov/16033679","citation_count":65,"is_preprint":false},{"pmid":"28473178","id":"PMC_28473178","title":"Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification.","date":"2017","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/28473178","citation_count":64,"is_preprint":false},{"pmid":"16155912","id":"PMC_16155912","title":"Cartducin, a paralog of Acrp30/adiponectin, is induced during chondrogenic differentiation and promotes proliferation of chondrogenic precursors and chondrocytes.","date":"2006","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16155912","citation_count":64,"is_preprint":false},{"pmid":"22233975","id":"PMC_22233975","title":"Adiponectin oligomerization state and adiponectin receptors airway expression in chronic obstructive pulmonary disease.","date":"2012","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/22233975","citation_count":63,"is_preprint":false},{"pmid":"12728641","id":"PMC_12728641","title":"The genetics of adiponectin.","date":"2003","source":"Current diabetes reports","url":"https://pubmed.ncbi.nlm.nih.gov/12728641","citation_count":63,"is_preprint":false},{"pmid":"11162643","id":"PMC_11162643","title":"Chromosomal localization, expression pattern, and promoter analysis of the mouse gene encoding adipocyte-specific secretory protein Acrp30.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11162643","citation_count":60,"is_preprint":false},{"pmid":"23432843","id":"PMC_23432843","title":"GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK.","date":"2013","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/23432843","citation_count":57,"is_preprint":false},{"pmid":"35932043","id":"PMC_35932043","title":"Segmentation, tracking and cell cycle analysis of live-cell imaging data with Cell-ACDC.","date":"2022","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/35932043","citation_count":55,"is_preprint":false},{"pmid":"17448181","id":"PMC_17448181","title":"Migraine and adiponectin: is there a connection?","date":"2007","source":"Cephalalgia : an international journal of headache","url":"https://pubmed.ncbi.nlm.nih.gov/17448181","citation_count":54,"is_preprint":false},{"pmid":"37686525","id":"PMC_37686525","title":"Role of Leptin and Adiponectin in Carcinogenesis.","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/37686525","citation_count":51,"is_preprint":false},{"pmid":"16443790","id":"PMC_16443790","title":"Interactions between noncontiguous haplotypes in the adiponectin gene ACDC are associated with plasma adiponectin.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16443790","citation_count":51,"is_preprint":false},{"pmid":"30791536","id":"PMC_30791536","title":"Pulmonary Hypertension and Obesity: Focus on Adiponectin.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30791536","citation_count":50,"is_preprint":false},{"pmid":"21397927","id":"PMC_21397927","title":"Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk.","date":"2011","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/21397927","citation_count":48,"is_preprint":false},{"pmid":"27061803","id":"PMC_27061803","title":"Adiponectin and colorectal cancer.","date":"2016","source":"Surgery today","url":"https://pubmed.ncbi.nlm.nih.gov/27061803","citation_count":46,"is_preprint":false},{"pmid":"27155572","id":"PMC_27155572","title":"Review: adiponectin in retinopathy.","date":"2016","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/27155572","citation_count":46,"is_preprint":false},{"pmid":"31456747","id":"PMC_31456747","title":"Potential Adiponectin Receptor Response Modifier Therapeutics.","date":"2019","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31456747","citation_count":45,"is_preprint":false},{"pmid":"24417948","id":"PMC_24417948","title":"Cardiometabolic effects of adiponectin.","date":"2013","source":"Best practice & research. Clinical endocrinology & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24417948","citation_count":45,"is_preprint":false},{"pmid":"29115433","id":"PMC_29115433","title":"Adiponectin promotes preadipocyte differentiation via the PPARγ pathway.","date":"2017","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/29115433","citation_count":44,"is_preprint":false},{"pmid":"22449616","id":"PMC_22449616","title":"Genetics of adiponectin.","date":"2012","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/22449616","citation_count":42,"is_preprint":false},{"pmid":"16421345","id":"PMC_16421345","title":"ACDC/adiponectin and PPAR-gamma gene polymorphisms: implications for features of obesity.","date":"2005","source":"Obesity research","url":"https://pubmed.ncbi.nlm.nih.gov/16421345","citation_count":42,"is_preprint":false},{"pmid":"22327423","id":"PMC_22327423","title":"Acrp30 inhibits leptin-induced metastasis by downregulating the JAK/STAT3 pathway via AMPK activation in aggressive SPEC-2 endometrial cancer cells.","date":"2012","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/22327423","citation_count":42,"is_preprint":false},{"pmid":"17966120","id":"PMC_17966120","title":"Circulating adiponectin and adiponectin receptor expression in skeletal muscle: effects of exercise.","date":"2007","source":"Diabetes/metabolism research and reviews","url":"https://pubmed.ncbi.nlm.nih.gov/17966120","citation_count":41,"is_preprint":false},{"pmid":"22876926","id":"PMC_22876926","title":"Adiponectin in metabolic bone disease.","date":"2012","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22876926","citation_count":41,"is_preprint":false},{"pmid":"39106421","id":"PMC_39106421","title":"Adiponectin and Adiponectin Receptors in Atherosclerosis.","date":"2025","source":"Endocrine reviews","url":"https://pubmed.ncbi.nlm.nih.gov/39106421","citation_count":40,"is_preprint":false},{"pmid":"20625941","id":"PMC_20625941","title":"Adiponectin and breast cancer.","date":"2010","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20625941","citation_count":40,"is_preprint":false},{"pmid":"24740426","id":"PMC_24740426","title":"Association of adiponectin gene (ADIPOQ) rs2241766 polymorphism with obesity in adults: a meta-analysis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24740426","citation_count":40,"is_preprint":false},{"pmid":"23017716","id":"PMC_23017716","title":"Glucocorticoid effects on adiponectin expression.","date":"2012","source":"Vitamins and hormones","url":"https://pubmed.ncbi.nlm.nih.gov/23017716","citation_count":39,"is_preprint":false},{"pmid":"29540173","id":"PMC_29540173","title":"Adiponectin and adiponectin receptor 1 overexpression enhance inflammatory bowel disease.","date":"2018","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/29540173","citation_count":39,"is_preprint":false},{"pmid":"24417947","id":"PMC_24417947","title":"Adiponectin effects on the kidney.","date":"2013","source":"Best practice & research. Clinical endocrinology & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24417947","citation_count":38,"is_preprint":false},{"pmid":"30386464","id":"PMC_30386464","title":"Adiponectin as a novel biomarker for liver fibrosis.","date":"2018","source":"World journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/30386464","citation_count":38,"is_preprint":false},{"pmid":"11244461","id":"PMC_11244461","title":"Characterization of mouse GBP28 and its induction by exposure to cold.","date":"2001","source":"International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/11244461","citation_count":37,"is_preprint":false},{"pmid":"17763181","id":"PMC_17763181","title":"Adiponectin, obesity and atherosclerosis.","date":"2007","source":"Scandinavian journal of clinical and laboratory investigation","url":"https://pubmed.ncbi.nlm.nih.gov/17763181","citation_count":37,"is_preprint":false},{"pmid":"20332107","id":"PMC_20332107","title":"Dimerization of adiponectin receptor 1 is inhibited by adiponectin.","date":"2010","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/20332107","citation_count":37,"is_preprint":false},{"pmid":"23401034","id":"PMC_23401034","title":"Adiponectin modulates NK-cell function.","date":"2013","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23401034","citation_count":36,"is_preprint":false},{"pmid":"36428526","id":"PMC_36428526","title":"Targeting Adiponectin in Breast Cancer.","date":"2022","source":"Biomedicines","url":"https://pubmed.ncbi.nlm.nih.gov/36428526","citation_count":35,"is_preprint":false},{"pmid":"18269182","id":"PMC_18269182","title":"Adiponectin and adiponectin receptors in obesity-linked insulin resistance.","date":"2007","source":"Novartis Foundation symposium","url":"https://pubmed.ncbi.nlm.nih.gov/18269182","citation_count":35,"is_preprint":false},{"pmid":"39287861","id":"PMC_39287861","title":"Adiponectin Resistance in Obesity: Adiponectin Leptin/Insulin Interaction.","date":"2024","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/39287861","citation_count":33,"is_preprint":false},{"pmid":"25223469","id":"PMC_25223469","title":"Association of ADIPOQ polymorphisms with obesity risk: a meta-analysis.","date":"2014","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25223469","citation_count":33,"is_preprint":false},{"pmid":"34959666","id":"PMC_34959666","title":"An Explanation for the Adiponectin Paradox.","date":"2021","source":"Pharmaceuticals (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/34959666","citation_count":31,"is_preprint":false},{"pmid":"22492282","id":"PMC_22492282","title":"Adiponectin, adiponectin receptors, and epigenetic regulation of adipogenesis.","date":"2012","source":"Cold Spring Harbor symposia on quantitative biology","url":"https://pubmed.ncbi.nlm.nih.gov/22492282","citation_count":31,"is_preprint":false},{"pmid":"25760347","id":"PMC_25760347","title":"Adiponectin in asthma: implications for phenotyping.","date":"2015","source":"Current protein & peptide science","url":"https://pubmed.ncbi.nlm.nih.gov/25760347","citation_count":31,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45516,"output_tokens":5235,"usd":0.107536,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13825,"output_tokens":4433,"usd":0.089975,"stage2_stop_reason":"end_turn"},"total_usd":0.197511,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"ADIPOQ (GBP28/apM1) was isolated from human plasma as a gelatin-binding protein. Structural analysis revealed it is encoded by the adipose-specific apM1 cDNA and contains a secretory signal sequence, collagen-like repeats, and a globular C-terminal domain, enabling homo-trimer formation and higher-order oligomeric complexes via its collagen-like domain.\",\n      \"method\": \"Affinity purification on gelatin-Cellulofine, N-terminal amino acid sequencing, protease peptide mapping, SDS-PAGE under reducing and non-reducing conditions, gel chromatography, cDNA sequence matching\",\n      \"journal\": \"Journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct biochemical purification and structural characterization with multiple orthogonal methods in the founding paper\",\n      \"pmids\": [\"8947845\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A single injection of recombinant Acrp30 in mice transiently lowered basal glucose levels and abolished hyperglycemia in ob/ob, NOD, and streptozotocin-treated mice independent of changes in insulin levels. In isolated hepatocytes, Acrp30 enhanced the ability of sub-physiological insulin to suppress glucose production, identifying the liver as a primary target organ.\",\n      \"method\": \"Intraperitoneal injection of purified recombinant protein in multiple mouse models; isolated hepatocyte glucose production assay\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo rescue experiments in multiple disease models plus ex vivo hepatocyte assay; replicated across conditions\",\n      \"pmids\": [\"11479628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Acrp30 infusion during a pancreatic euglycemic clamp in conscious mice caused a ~65% reduction in endogenous glucose production and reduced hepatic gluconeogenic enzyme mRNAs (PEPCK and G6Pase) by >50%, without affecting peripheral glucose uptake, glycolysis, or glycogen synthesis, establishing hepatic gluconeogenesis suppression as the primary mechanism of Acrp30-mediated glucose lowering.\",\n      \"method\": \"Pancreatic euglycemic clamp with intravenous Acrp30 infusion; isotopic glucose flux measurements; hepatic enzyme mRNA quantification\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — quantitative in vivo clamp methodology with isotopic tracers and molecular readouts, single rigorous study with multiple orthogonal methods\",\n      \"pmids\": [\"11748271\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Adiponectin/ACRP30 knockout mice showed delayed clearance of plasma free fatty acids, reduced FATP-1 mRNA in muscle, elevated adipose TNF-alpha mRNA and plasma TNF-alpha, and severe diet-induced insulin resistance with reduced IRS-1-associated PI3-kinase activity in muscle. Viral re-expression of adiponectin reversed these defects, placing adiponectin upstream of FATP-1 expression and IRS-1-mediated insulin signaling in muscle.\",\n      \"method\": \"Gene knockout mouse model, viral-mediated gene rescue, muscle PI3-kinase activity assay, cultured myocyte TNF-alpha/adiponectin treatment\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic KO with specific molecular phenotype, rescue experiment, and in vitro validation; multiple orthogonal methods\",\n      \"pmids\": [\"12068289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Acrp30 circulates as trimeric and high-molecular-weight (HMW) oligomeric complexes whose distribution shows sexual dimorphism (females have more HMW). Disulfide bonds via Cys-39 are required for HMW complex formation. Mutation of Cys-39 (C39S) produces trimers that are more bioactive than HMW forms in reducing serum glucose and suppressing hepatic glucose output in primary hepatocytes, demonstrating that oligomerization state regulates bioactivity.\",\n      \"method\": \"SDS-PAGE, size-exclusion chromatography, site-directed mutagenesis (Cys-39), DTT reduction, in vivo glucose assay, primary hepatocyte glucose output assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis combined with in vitro and in vivo functional assays in a single rigorous study\",\n      \"pmids\": [\"12496257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Hexameric and higher molecular weight (HMW) isoforms of Acrp30 activate NF-κB in C2C12 myocytes via phosphorylation and degradation of IκB-alpha, whereas trimeric Acrp30 and globular domain (gAcrp30) do not, establishing oligomerization-state-dependent NF-κB signaling.\",\n      \"method\": \"NF-κB reporter assay, Western blot for IκB-α phosphorylation/degradation, size-fractionated Acrp30 preparations from E. coli and HEK293T cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical fractionation combined with functional reporter and mechanistic Western blot in a single study\",\n      \"pmids\": [\"12087086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Trimeric Acrp30 (but not hexameric or HMW forms) activates AMP-activated protein kinase alpha (phosphorylation at Thr172) in isolated rat muscle. Conversely, HMW and hexameric Acrp30 activate NF-κB but trimers do not. Cys-22 disulfide bonds are required for hexamer/HMW formation but not trimer stability, establishing that different oligomeric forms activate distinct signaling pathways.\",\n      \"method\": \"Freeze-etch electron microscopy, site-directed mutagenesis (Cys22 to Ala), DTT reduction, AMPK phosphorylation assay in isolated muscle, NF-κB reporter assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structural EM, mutagenesis, and orthogonal functional assays in a single rigorous study\",\n      \"pmids\": [\"14522956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"T-cadherin was identified as a binding receptor for hexameric and HMW species of adiponectin, but not for trimeric or globular species. Binding requires eukaryotic post-translational modifications on adiponectin and the N-terminal cysteine required for hexamer/HMW formation; a C-terminal cysteine mutant that cannot form hexamers/HMW failed to bind T-cadherin in co-immunoprecipitation.\",\n      \"method\": \"Retroviral cDNA expression library screen, magnetic bead panning for adiponectin binding, co-immunoprecipitation, T-cadherin overexpression in Ba/F3 cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — expression cloning-based receptor identification confirmed by Co-IP and isoform-specific binding assays with mutagenesis\",\n      \"pmids\": [\"15210937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"APPL1 (adaptor protein with PTB, PH and leucine zipper domains) was identified as a direct binding partner of AdipoR1 intracellular domain by yeast two-hybrid. APPL1 interaction with adiponectin receptors in mammalian cells is stimulated by adiponectin. APPL1 overexpression increases, and APPL1 knockdown reduces, adiponectin-stimulated lipid oxidation, glucose uptake, and GLUT4 membrane translocation. Adiponectin also stimulates APPL1–Rab5 interaction, promoting GLUT4 translocation. APPL1 mediates cross-talk between adiponectin and insulin signaling pathways.\",\n      \"method\": \"Yeast two-hybrid screening, co-immunoprecipitation in mammalian cells, APPL1 overexpression/siRNA knockdown, lipid oxidation assay, glucose uptake assay, GLUT4 translocation assay\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid discovery confirmed by reciprocal Co-IP, multiple orthogonal functional readouts, gain- and loss-of-function\",\n      \"pmids\": [\"16622416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The GBP28/ADIPOQ gene was mapped to human chromosome 3q27 by FISH and found to span 16 kb with 3 exons and 2 introns. The gene lacks a TATA box and its exon-intron organization resembles the leptin gene, providing structural basis for understanding its transcriptional regulation.\",\n      \"method\": \"Genomic cloning (lambda and BAC clones), FISH chromosomal mapping, sequence analysis of exon-intron boundaries\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct genomic structural characterization by cloning and FISH; single lab, primarily structural without functional validation\",\n      \"pmids\": [\"10095105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"GBP28/adiponectin expression is normally absent in mouse liver, but after CCl4-induced hepatic injury, circulating GBP28 binds to hepatocyte extracellular matrix early (3–6 h), and GBP28 mRNA is subsequently markedly induced in damaged hepatocytes. IL-6 treatment of human HepG2 hepatoma cells also induced GBP28 expression, identifying liver as a secondary production site regulated by injury and inflammatory signals.\",\n      \"method\": \"Immunohistochemistry, quantitative RT-PCR, in situ hybridization in CCl4-treated mouse liver; IL-6 treatment of HepG2 cells\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple detection methods (IHC, qRT-PCR, ISH) in vivo plus in vitro IL-6 stimulation; single lab\",\n      \"pmids\": [\"11444852\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Mouse Acrp30 gene was mapped to the telomere of chromosome 16 (syntenic to human 3q27), and alternative polyadenylation produces two distinct mRNA species. Acrp30 expression is induced only at late stages of mouse embryonic development. The promoter was shown to drive strong adipocyte-specific expression in tissue culture cells.\",\n      \"method\": \"Chromosomal mapping, RT-PCR for alternative polyadenylation, developmental expression analysis, promoter-reporter assays in tissue culture\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct experimental mapping and promoter functional assay; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"11162643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"AdipoR1 forms endogenous homodimers in multiple cell lines and human muscle tissue. A GxxxG motif in the fifth transmembrane domain is required for dimerization; mutation of both glycines (to Phe or Glu) disrupts dimerization. Adiponectin decreases AdipoR1 dimerization in a concentration-dependent manner, with this effect primarily mediated by the collagen-like domain of full-length adiponectin.\",\n      \"method\": \"Bimolecular fluorescence complementation (BiFC), flow cytometry, site-directed mutagenesis of GxxxG motif, Western blot of endogenous AdipoR1 in human muscle\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of specific dimerization motif combined with BiFC and endogenous protein detection; single lab with multiple orthogonal methods\",\n      \"pmids\": [\"20332107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"TNF-alpha reduces apM1 expression and secretion in differentiating primary human preadipocytes, while dibutyryl-cAMP also reduces expression. Ionomycin increases secretion of apM1. These findings establish transcriptional/secretory regulatory mechanisms for ADIPOQ in human adipocytes.\",\n      \"method\": \"Primary human preadipocyte differentiation culture, polyclonal antibody for apM1 detection, pharmacological treatments (ionomycin, db-cAMP, TNF-alpha), glycerol-3-phosphate dehydrogenase activity as differentiation marker\",\n      \"journal\": \"Hormone and metabolic research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct measurement of protein expression and secretion with multiple pharmacological treatments; single lab, no rescue or mechanistic depth\",\n      \"pmids\": [\"11246823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Uncarboxylated osteocalcin (GluOC) induces adiponectin expression in adipocytes via GPRC6A receptor activation → cAMP accumulation → PKA activation → Src → Rap1 → ERK → CREB phosphorylation → PPARγ upregulation → adiponectin expression. ERK inhibition (U0126) blocked CREB phosphorylation. In vivo, oral GluOC in mice increased PPARγ and adiponectin expression in gonadal white adipocytes.\",\n      \"method\": \"3T3-L1 adipocyte differentiation assay, pharmacological inhibitors (U0126, PKA inhibitors), Western blot for signaling intermediates, in vivo mouse oral GluOC administration\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway dissection with pharmacological inhibitors and in vivo confirmation; single lab\",\n      \"pmids\": [\"25562427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Adiponectin/AdipoR1 signaling in muscle regulates mitochondrial biogenesis via AMPK- and SIRT1-mediated PGC-1α activation and Ca2+-dependent upregulation of PGC-1α expression. Muscle-specific AdipoR1 knockout mice had impaired mitochondrial biogenesis and insulin resistance, revealing this as the mechanistic basis for adiponectin's insulin-sensitizing effect in muscle.\",\n      \"method\": \"Muscle-specific AdipoR1 knockout mouse, mitochondrial biogenesis assays, AMPK/SIRT1/PGC-1α pathway analysis\",\n      \"journal\": \"Cold Spring Harbor symposia on quantitative biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — tissue-specific genetic knockout with specific molecular phenotype; single lab, conference proceedings (less rigorous venue)\",\n      \"pmids\": [\"22492282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Macrophage polarization state controls AdipoR1/R2 expression and adiponectin signaling outcome: classical M1 activation suppresses AdipoR expression (40–60% reduction) and causes adiponectin to induce pro-inflammatory cytokines (TNF-α, IL-6, IL-12 >10-fold), whereas M2 activation preserves AdipoR expression and adiponectin induces anti-inflammatory IL-10. Adiponectin upregulates AdipoR mRNA and protein in macrophages via LXRα.\",\n      \"method\": \"Mouse bone marrow and peritoneal macrophage polarization, cytokine ELISA/multiplex, AdipoR mRNA/protein quantification, LXRα pathway analysis\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple cell types, defined polarization conditions, mechanistic pathway (LXRα); single lab\",\n      \"pmids\": [\"25392268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Acrp30 inhibits leptin-induced invasion of SPEC-2 endometrial cancer cells by activating AMPK and thereby reducing STAT3 phosphorylation and nuclear translocation, with downstream reduction of MMP-2 and MMP-9. JAK/STAT3 inhibitor and AMPK inhibitor experiments confirmed the pathway: Acrp30 acts via AMPK to suppress the JAK/STAT3 axis activated by leptin.\",\n      \"method\": \"Matrigel transwell invasion assay, Western blot for STAT3 phosphorylation, cell immunofluorescence for STAT3 nuclear translocation, pharmacological inhibitors (AG490, Compound C, IL-6), qRT-PCR for MMP-2/MMP-9\",\n      \"journal\": \"Oncology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway placed by pharmacological epistasis with multiple inhibitors and multiple molecular readouts; single lab\",\n      \"pmids\": [\"22327423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Adiponectin null mice display exacerbated age-related glucose and lipid metabolism disorders and shortened lifespan on both chow and high-fat diet. Transgenic mice with elevated circulating adiponectin have improved systemic insulin sensitivity, reduced age-related tissue inflammation and fibrosis, and prolonged healthspan and median lifespan, establishing adiponectin as a direct regulator of aging and longevity.\",\n      \"method\": \"Adiponectin knockout mouse aging study, adiponectin transgenic overexpression mouse, glucose/lipid metabolism assays, histological assessment of tissue inflammation and fibrosis, lifespan analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — bidirectional genetic manipulation (KO and transgenic overexpression) with specific metabolic and longevity phenotypes; rigorous experimental design\",\n      \"pmids\": [\"33904399\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ADIPOQ (adiponectin/Acrp30/GBP28) is an adipocyte-secreted collagen-domain-containing protein that circulates as trimeric, hexameric, and high-molecular-weight oligomers; trimers preferentially activate AMP-activated protein kinase (AMPK) in muscle while hexameric/HMW forms activate NF-κB, and HMW forms bind T-cadherin on vascular cells. Its primary metabolic actions are suppression of hepatic gluconeogenesis (reducing PEPCK and G6Pase expression) and enhancement of muscle fatty acid oxidation and glucose uptake via IRS-1/PI3-kinase and AMPK/SIRT1/PGC-1α pathways, with APPL1 serving as the intracellular adaptor linking AdipoR1/R2 to downstream signaling including GLUT4 translocation and cross-talk with insulin signaling.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ADIPOQ encodes adiponectin (GBP28/apM1/Acrp30), an adipocyte-secreted, collagen-domain protein that acts as a systemic regulator of glucose and lipid metabolism, insulin sensitivity, and organismal healthspan [#0, #18]. Originally purified from plasma as a gelatin-binding protein with a signal sequence, collagen-like repeats, and a globular C-terminal domain, it assembles into trimers, hexamers, and high-molecular-weight (HMW) oligomers, with interchain disulfide bonds through Cys-39/Cys-22 required for higher-order assembly [#0, #4, #6]. Oligomerization state dictates signaling output: trimers preferentially activate AMPK (Thr172 phosphorylation) in muscle, while hexameric and HMW forms drive NF-κB signaling via IκB-α degradation, and only hexamer/HMW species bind the receptor T-cadherin in a manner dependent on eukaryotic post-translational modification [#4, #5, #6, #7]. Its principal metabolic action is suppression of hepatic glucose output — in vivo it reduces endogenous glucose production and downregulates the gluconeogenic enzymes PEPCK and G6Pase, sensitizing the liver to insulin [#1, #2]. In muscle, adiponectin signaling supports IRS-1-associated PI3-kinase activity, FATP-1 expression, free fatty acid clearance, and AMPK/SIRT1/PGC-1α-driven mitochondrial biogenesis, as established by adiponectin and muscle-specific AdipoR1 knockouts [#3, #15]. Intracellular signal transmission depends on the adaptor APPL1, which binds the AdipoR1 cytoplasmic domain, is recruited upon adiponectin stimulation, and links receptor engagement to lipid oxidation, glucose uptake, GLUT4 translocation (via Rab5), and cross-talk with insulin signaling [#8]. Adiponectin expression is regulated transcriptionally — suppressed by TNF-α and induced through a GPRC6A→cAMP/PKA→ERK/CREB→PPARγ axis by uncarboxylated osteocalcin — and its actions extend to context-dependent modulation of macrophage inflammation and lifespan extension [#13, #14, #16, #18].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established the molecular identity and architecture of adiponectin, defining the structural basis for its oligomerization.\",\n      \"evidence\": \"Affinity purification from human plasma, N-terminal sequencing, peptide mapping, and reducing/non-reducing SDS-PAGE\",\n      \"pmids\": [\"8947845\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define receptors or signaling\", \"Functional role of oligomers unaddressed at this stage\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapped the gene to 3q27 and characterized its exon-intron and promoter structure, providing the genomic basis for transcriptional regulation.\",\n      \"evidence\": \"Genomic cloning and FISH chromosomal mapping with exon-intron boundary sequencing\",\n      \"pmids\": [\"10095105\", \"11162643\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional transcription factor identification\", \"Promoter activity only shown in tissue culture\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identified the liver as a primary target and pinpointed suppression of hepatic gluconeogenesis as the dominant glucose-lowering mechanism, distinguishing it from peripheral glucose uptake.\",\n      \"evidence\": \"Recombinant protein injection in multiple diabetic mouse models, hepatocyte glucose-production assays, and pancreatic euglycemic clamp with isotopic tracers and PEPCK/G6Pase mRNA quantification\",\n      \"pmids\": [\"11479628\", \"11748271\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor mediating hepatic action not identified\", \"Did not connect to specific oligomeric form\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Genetic loss-of-function placed adiponectin upstream of muscle FATP-1 expression and IRS-1/PI3-kinase insulin signaling, mechanistically linking it to insulin resistance.\",\n      \"evidence\": \"Adiponectin knockout mouse with viral rescue, muscle PI3-kinase activity assays, and myocyte treatment\",\n      \"pmids\": [\"12068289\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve receptor or intracellular adaptor\", \"Relationship between TNF-α elevation and insulin resistance correlative\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrated that oligomerization state — controlled by Cys-39 disulfide bonds — determines bioactivity and signaling pathway selection.\",\n      \"evidence\": \"Size-exclusion chromatography, Cys-39 mutagenesis, in vivo glucose assays, hepatocyte glucose output, and NF-κB reporter/IκB-α Western blots with size-fractionated preparations\",\n      \"pmids\": [\"12496257\", \"12087086\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptors for distinct oligomers not yet identified\", \"Physiological determinants of oligomer distribution beyond sex unclear\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Resolved that trimers selectively activate AMPK while hexamer/HMW forms selectively activate NF-κB, formalizing oligomer-specific pathway routing.\",\n      \"evidence\": \"Freeze-etch EM, Cys-22 mutagenesis, AMPK Thr172 phosphorylation in isolated muscle, and NF-κB reporter assays\",\n      \"pmids\": [\"14522956\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Receptor coupling each oligomer to its pathway not defined\", \"In vivo relevance of NF-κB branch unaddressed\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified T-cadherin as an oligomer-selective receptor binding hexamer/HMW species, explaining how oligomeric state confers receptor specificity.\",\n      \"evidence\": \"Retroviral expression cloning, magnetic-bead panning, co-immunoprecipitation, and isoform-specific binding with cysteine mutants\",\n      \"pmids\": [\"15210937\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream signaling from T-cadherin not established\", \"T-cadherin lacks intracellular domain, leaving transduction mechanism open\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identified APPL1 as the intracellular adaptor coupling AdipoR1 to metabolic effectors and insulin cross-talk, providing the missing intracellular link.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal Co-IP, gain/loss-of-function, and lipid oxidation, glucose uptake, and GLUT4 translocation assays\",\n      \"pmids\": [\"16622416\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of APPL1–AdipoR1 interaction not defined\", \"Relationship to AMPK activation branch incompletely resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Showed AdipoR1 forms GxxxG-dependent homodimers that adiponectin disrupts, indicating ligand-regulated receptor oligomerization as a signaling event.\",\n      \"evidence\": \"BiFC, flow cytometry, GxxxG-motif mutagenesis, and endogenous AdipoR1 detection in human muscle\",\n      \"pmids\": [\"20332107\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of dimer disruption for downstream signaling not quantified\", \"Whether AdipoR2 behaves identically untested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mechanistically tied muscle AdipoR1 signaling to AMPK/SIRT1/PGC-1α-driven mitochondrial biogenesis as the basis of insulin sensitization.\",\n      \"evidence\": \"Muscle-specific AdipoR1 knockout mice with mitochondrial biogenesis and pathway analyses\",\n      \"pmids\": [\"22492282\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Conference-proceedings venue\", \"Ca2+ and AMPK contributions not fully separated\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Extended adiponectin's AMPK action beyond metabolism, showing it suppresses leptin-driven JAK/STAT3 signaling and MMP expression in cancer cells.\",\n      \"evidence\": \"Invasion assays, STAT3 phosphorylation/nuclear-translocation analysis, and pharmacological epistasis (AG490, Compound C)\",\n      \"pmids\": [\"22327423\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell line\", \"Receptor mediating the anti-invasive effect not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined the upstream transcriptional regulation of adiponectin and the macrophage-state-dependence of its inflammatory output.\",\n      \"evidence\": \"Macrophage polarization with cytokine profiling and LXRα analysis; preadipocyte differentiation with pharmacological treatments (TNF-α, cAMP, ionomycin)\",\n      \"pmids\": [\"25392268\", \"11246823\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct transcription factors at the ADIPOQ promoter not fully mapped\", \"In vivo relevance of macrophage polarization switch untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified an osteocalcin–GPRC6A signaling cascade that induces adiponectin via PPARγ, linking bone-derived signals to adipokine expression.\",\n      \"evidence\": \"3T3-L1 differentiation, pharmacological inhibitor dissection (U0126, PKA inhibitors), and in vivo oral GluOC administration\",\n      \"pmids\": [\"25562427\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Quantitative contribution to circulating adiponectin in vivo unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Bidirectional genetic manipulation established adiponectin as a direct regulator of healthspan and lifespan, not merely acute metabolism.\",\n      \"evidence\": \"Adiponectin knockout and transgenic overexpression mouse lifespan studies with metabolic and histological assessment\",\n      \"pmids\": [\"33904399\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mediators of longevity effect not pinpointed\", \"Whether oligomer- or receptor-specific signaling underlies the phenotype unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How distinct oligomeric forms are coupled to specific receptors (AdipoR1/R2, T-cadherin) and intracellular adaptors to produce divergent metabolic, inflammatory, and longevity outcomes in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified structural model linking oligomer to receptor to pathway\", \"T-cadherin transduction mechanism undefined\", \"Mediators of lifespan extension unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [1, 7, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 3, 6]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 4, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 4]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [10]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 8]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 3, 15]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [5, 16]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CDH13\", \"APPL1\", \"ADIPOR1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}